Matches in SemOpenAlex for { <https://semopenalex.org/work/W2028399237> ?p ?o ?g. }
- W2028399237 endingPage "1412" @default.
- W2028399237 startingPage "1405" @default.
- W2028399237 abstract "Abstract In this double-blind, placebo-controlled study, 363 patients with untreated multiple myeloma were randomized to receive either melphalan-prednisone and thalidomide (MPT) or melphalan-prednisone and placebo (MP). The dose of melphalan was 0.25 mg/kg and prednisone was 100 mg given daily for 4 days every 6 weeks until plateau phase. The dose of thalidomide/placebo was escalated to 400 mg daily until plateau phase and thereafter reduced to 200 mg daily until progression. A total of 357 patients were analyzed. Partial response was 34% and 33%, and very good partial response or better was 23% and 7% in the MPT and MP arms, respectively (P < .001). There was no significant difference in progression-free or overall survival, with median survival being 29 months in the MPT arm and 32 months in the MP arm. Most quality of life outcomes improved equally in both arms, apart from constipation, which was markedly increased in the MPT arm. Constipation, neuropathy, nonneuropathy neurologic toxicity, and skin reactions were significantly more frequent in the MPT arm. The number of thromboembolic events was equal in the 2 treatment arms. In conclusion, MPT had a significant antimyeloma effect, but this did not translate into improved survival. This trial was registered at www.clinicaltrials.gov as #NCT00218855." @default.
- W2028399237 created "2016-06-24" @default.
- W2028399237 creator A5003689547 @default.
- W2028399237 creator A5012496389 @default.
- W2028399237 creator A5014322334 @default.
- W2028399237 creator A5022052738 @default.
- W2028399237 creator A5027908456 @default.
- W2028399237 creator A5028791599 @default.
- W2028399237 creator A5029832651 @default.
- W2028399237 creator A5030025538 @default.
- W2028399237 creator A5030094794 @default.
- W2028399237 creator A5032749299 @default.
- W2028399237 creator A5034029591 @default.
- W2028399237 creator A5042043392 @default.
- W2028399237 creator A5042205038 @default.
- W2028399237 creator A5042210414 @default.
- W2028399237 creator A5051008993 @default.
- W2028399237 creator A5059820248 @default.
- W2028399237 creator A5060699933 @default.
- W2028399237 creator A5061897927 @default.
- W2028399237 creator A5064614904 @default.
- W2028399237 creator A5068471072 @default.
- W2028399237 creator A5070319781 @default.
- W2028399237 creator A5072103544 @default.
- W2028399237 creator A5081919656 @default.
- W2028399237 creator A5082869425 @default.
- W2028399237 creator A5086469926 @default.
- W2028399237 date "2010-09-02" @default.
- W2028399237 modified "2023-10-18" @default.
- W2028399237 title "Melphalan and prednisone plus thalidomide or placebo in elderly patients with multiple myeloma" @default.
- W2028399237 cites W1963909872 @default.
- W2028399237 cites W1988092780 @default.
- W2028399237 cites W2020778579 @default.
- W2028399237 cites W2082741854 @default.
- W2028399237 cites W2097331346 @default.
- W2028399237 cites W2101576302 @default.
- W2028399237 cites W2110466835 @default.
- W2028399237 cites W2117172636 @default.
- W2028399237 cites W2118443286 @default.
- W2028399237 cites W2137364855 @default.
- W2028399237 cites W2143860449 @default.
- W2028399237 cites W2148188974 @default.
- W2028399237 cites W2161375627 @default.
- W2028399237 cites W2316160054 @default.
- W2028399237 cites W4214559180 @default.
- W2028399237 doi "https://doi.org/10.1182/blood-2009-08-237974" @default.
- W2028399237 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20448107" @default.
- W2028399237 hasPublicationYear "2010" @default.
- W2028399237 type Work @default.
- W2028399237 sameAs 2028399237 @default.
- W2028399237 citedByCount "215" @default.
- W2028399237 countsByYear W20283992372012 @default.
- W2028399237 countsByYear W20283992372013 @default.
- W2028399237 countsByYear W20283992372014 @default.
- W2028399237 countsByYear W20283992372015 @default.
- W2028399237 countsByYear W20283992372016 @default.
- W2028399237 countsByYear W20283992372017 @default.
- W2028399237 countsByYear W20283992372018 @default.
- W2028399237 countsByYear W20283992372019 @default.
- W2028399237 countsByYear W20283992372020 @default.
- W2028399237 countsByYear W20283992372021 @default.
- W2028399237 countsByYear W20283992372022 @default.
- W2028399237 countsByYear W20283992372023 @default.
- W2028399237 crossrefType "journal-article" @default.
- W2028399237 hasAuthorship W2028399237A5003689547 @default.
- W2028399237 hasAuthorship W2028399237A5012496389 @default.
- W2028399237 hasAuthorship W2028399237A5014322334 @default.
- W2028399237 hasAuthorship W2028399237A5022052738 @default.
- W2028399237 hasAuthorship W2028399237A5027908456 @default.
- W2028399237 hasAuthorship W2028399237A5028791599 @default.
- W2028399237 hasAuthorship W2028399237A5029832651 @default.
- W2028399237 hasAuthorship W2028399237A5030025538 @default.
- W2028399237 hasAuthorship W2028399237A5030094794 @default.
- W2028399237 hasAuthorship W2028399237A5032749299 @default.
- W2028399237 hasAuthorship W2028399237A5034029591 @default.
- W2028399237 hasAuthorship W2028399237A5042043392 @default.
- W2028399237 hasAuthorship W2028399237A5042205038 @default.
- W2028399237 hasAuthorship W2028399237A5042210414 @default.
- W2028399237 hasAuthorship W2028399237A5051008993 @default.
- W2028399237 hasAuthorship W2028399237A5059820248 @default.
- W2028399237 hasAuthorship W2028399237A5060699933 @default.
- W2028399237 hasAuthorship W2028399237A5061897927 @default.
- W2028399237 hasAuthorship W2028399237A5064614904 @default.
- W2028399237 hasAuthorship W2028399237A5068471072 @default.
- W2028399237 hasAuthorship W2028399237A5070319781 @default.
- W2028399237 hasAuthorship W2028399237A5072103544 @default.
- W2028399237 hasAuthorship W2028399237A5081919656 @default.
- W2028399237 hasAuthorship W2028399237A5082869425 @default.
- W2028399237 hasAuthorship W2028399237A5086469926 @default.
- W2028399237 hasBestOaLocation W20283992371 @default.
- W2028399237 hasConcept C126322002 @default.
- W2028399237 hasConcept C126894567 @default.
- W2028399237 hasConcept C141071460 @default.
- W2028399237 hasConcept C142724271 @default.
- W2028399237 hasConcept C204787440 @default.
- W2028399237 hasConcept C27081682 @default.
- W2028399237 hasConcept C2776364478 @default.
- W2028399237 hasConcept C2778684742 @default.